Palomino Laboratories (PALX) Cash from Operations (2023 - 2025)

Palomino Laboratories' (PALX) quarterly Cash from Operations came in at 343500.0 in Q3 2025, down 1189.47% year-on-year from 31529.0 in Q3 2024, and down 582.29% quarter-over-quarter from 50345.0 in Q2 2025.

Palomino Laboratories (PALX) Cash from Operations (2023 - 2025) Analysis & Trends

Palomino Laboratories has disclosed Cash from Operations across 3 years of filings, most recently posting 343500.0 for Q3 2025.

  • Cash from Operations for Q3 2025 came in at 343500.0, down 1189.47% year-over-year; the trailing twelve-month figure through Sep 2025 was 558260.0 (changed N/A YoY), and the FY2024 annual result was 166637.0, down 109.93% from the prior year.
  • Cash from Operations came in at 343500.0 for Q3 2025 at Palomino Laboratories, down from 50345.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 31529.0 in Q3 2024 to a low of 343500.0 in Q3 2025.
  • The 3-year median for Cash from Operations is 53555.5 (2023), against an average of 97249.5.
  • Across the five-year window, Cash from Operations plunged 195.01% in 2024 and slumped 1189.47% in 2025, its largest moves.
  • Palomino Laboratories' Cash from Operations stood at 56766.0 in 2023, then slumped by 195.01% to 167467.0 in 2024, then slumped by 105.12% to 343500.0 in 2025.
  • The last three Cash from Operations figures came in at 343500.0 (Q3 2025), 50345.0 (Q2 2025), and 3052.0 (Q1 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -343,500.00
Sep 30, 2025 -343,500.00
Jun 30, 2025 -50,345.00
Jun 30, 2025 -50,345.00
Mar 31, 2025 3,052.00
Mar 31, 2025 3,052.00
Dec 31, 2024 -167,467.00
Dec 31, 2024 -167,467.00
Sep 30, 2024 31,529.00
Sep 30, 2024 31,529.00
Dec 31, 2023 -56,766.00
Dec 31, 2023 -56,766.00